Last reviewed · How we verify
NCT03866122
Evaluation of a Novel Neonatal Temperature Monitor
NA trial testing NTM Monitoring in Neonatal Hypothermia in 150 participants. Status unknown.
6 September 2022
Quick facts
| Lead sponsor | William Marsh Rice University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 150 |
| Start date | 6 September 2017 |
| Primary completion | 6 September 2022 |
| Estimated completion | 6 September 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- NTM Monitoring
Conditions studied
- Neonatal Hypothermia — all drugs for Neonatal Hypothermia →
Sponsor
William Marsh Rice University
Who can join
Under 28 Days, any sex, with Neonatal Hypothermia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A team of researchers at Rice University and Queen Elizabeth Central Hospital (QECH) are working to develop a low-cost temperature sensor that can continuously monitor an infant's temperature (NTM). This robust, low-cost device will allow for the individualized monitoring of each infant with alerts for hypo and hyperthermia. A reusable band placed around the infant's abdomen to hold the temperature sensor will eliminate disposable components. This study will assess the accuracy of this novel device against a gold standard (Philips Intellivue patient monitor) and up to two existing devices (Bempu and Thermospot).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evaluation of a continuous neonatal temperature monitor for low-resource settings: a device feasibility pilot study.
Sosa Saenz SE, Hardy MK, Heenan M, Oden ZM, et al · · 2020 · cited 1× · PMID 32426530 · DOI 10.1136/bmjpo-2020-000655
Verify or expand the search:
- PubMed search for NCT03866122
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neonatal Hypothermia
Currently open trials in the same condition.
- NCT07453264 — Effect of Thermoregulation Bundle Applied at Birth on Neonatal Physiological Parameters and Breastfeeding · NA · recruiting
- NCT06003140 — Efficacy of Celsi Warmer for the Management of Hypothermic Newborns at the Lagos University Teaching Hospital in Lagos, · NA · recruiting
Other William Marsh Rice University trials
Trials by the same sponsor.
- NCT07554417 — Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treat · Phase 4 · not yet recruiting
- NCT06003140 — Efficacy of Celsi Warmer for the Management of Hypothermic Newborns at the Lagos University Teaching Hospital in Lagos, · NA · recruiting
- NCT06000826 — Efficacy of Celsi Warmer for the Management of Hypothermic Newborns · NA · unknown
- NCT04905381 — Can the Language Environment Analysis Start Program Improve Children's Readiness for School? LENA Program Evaluation · NA · unknown
- NCT05876884 — Efficacy of a Low-cost Warming Mattress Celsi Warmer for the Management of Hypothermic Newborns at Muhimbili National Ho · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03866122 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by William Marsh Rice University
- Last refreshed: 10 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03866122.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing